In rodent models, intranasal administration of NGF increased VEGF serum levels, increased microvessel density in the penumbra region, improved neurological outcome, and reduced ischemic injury 7 days post-stroke (Li et al., 2018). This evidence concerns the gene VEGFA and stroke disorder.